Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02979730 · ClinicalTrials.gov registry record · NA
Impact of Rapid Flu Testing in BMC ED
A NA study, sponsored by Boston Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 233
- Enrollment target
NCT02979730: Completed NA study, sponsored by Boston Medical Center.
NCT02979730 is a NA study that has completed, run by Boston Medical Center. The registered enrollment target is 233 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02979730, a NA study, has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 233 participants
- Enrollment target
Study Summary
The purpose of the study is to compare Emergency Department patients who undergo influenza testing using an FDA-approved point-of-care device (Cobas Liat Influenza A/B assay) located in the ED, to patients whose samples are sent to the BMC central laboratory. Patients who agree to participate will have their samples randomly assigned to be tested on either at the core lab, or on the POC device. The current turnaround time for samples sent to the laboratory is approximately two hours; investigators expect that the point of care device can reduce this time. Investigators will determine if the time to disposition and the administration of antibiotics is different in the group undergoing POC influenza testing compared to those undergoing laboratory-based influenza testing
Primary Outcome
The time elapsed from when a patient was placed in the ED treatment room until the disposition (either admit, observe, or discharge) was ordered in the medical record
Interventions
- OTHER Core Lab Test
- OTHER ED Point of Care Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 233 participants |
| Start Date | 2017-02-07 |
| Est. Completion | 2017-12-01 |
| Phase | NA |
What the finished NCT02979730 record still lists
NCT02979730 is an interventional study that assigns participants to a tested intervention. The registered 233 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 2 interventions - of which Core Lab Test is the first listed.
NCT02979730 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02979730 about?
NCT02979730 is a clinical study titled "Impact of Rapid Flu Testing in BMC ED". The purpose of the study is to compare Emergency Department patients who undergo influenza testing using an FDA-approved point-of-care device (Cobas Liat Influenza A/B assay) located in the ED, to patients whose samples are sent to the BMC central laboratory. Patients who agree to participate will h...
What is the current status of trial NCT02979730?
This trial is currently completed. It is a NA study. The enrollment target is 233 participants. The study started on 2017-02-07. Estimated completion is 2017-12-01.
What interventions are being tested in trial NCT02979730?
The interventions under investigation include: Core Lab Test (OTHER), ED Point of Care Test (OTHER).
Who is sponsoring clinical trial NCT02979730?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02979730's enrollment target sits among peer trials
233 463rd of 2000 higher than 1,538 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06993844 · 233 participants · Phase 1
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
- NCT07141706 · 233 participants · Phase 1
A Study of DB-1317 in Selected Advanced/Metastatic Solid Tumors
- NCT04942717 · 234 participants · NA
Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values
- NCT05208671 · 234 participants · NA
Nutrition to Optimize, Understand, and Restore Insulin Sensitivity in HIV for Oklahoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI